Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. - Wikidata - wikimedia - TriplyDB

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q51492450

about

Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic Genetic background in nonalcoholic fatty liver disease: A comprehensive review Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.Major Components of Metabolic Parameters and Nutritional Intakes in Different Genotypes of Adiponectin +276 G>T Gene Polymorphism in Non-Diabetes and Non-Alcoholic Iranian Fatty Liver Patients.Pinus densiflora Sieb. et Zucc. alleviates lipogenesis and oxidative stress during oleic acid-induced steatosis in HepG2 cells.Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis Higher estimated net endogenous Acid production may be associated with increased prevalence of nonalcoholic Fatty liver disease in chinese adults in Hong Kong.High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.Current concepts in the pathogenesis of nonalcoholic fatty liver disease.How should we manage patients with non-alcoholic fatty liver disease in 2007?Effects of metabolic syndrome on fibrosis in chronic viral hepatitis Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease.Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy.The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.Fatty liver in childhood.Nonalcoholic steatohepatitis: risk factors and diagnosis.Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.Association of tumor necrosis factor-α gene promoter polymorphism at sites -308 and -238 with non-alcoholic fatty liver disease: a meta-analysis.Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Nonalcoholic fatty liver disease - current status and future directions.Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review.Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study.Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.Sex-influenced association of non-alcoholic fatty liver disease with colorectal adenomatous and hyperplastic polyps.Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps.

P2860

Q24563381-3260AE37-8398-4358-ADF0-1B05FC91C61D Q26780248-C2793411-07D8-464A-9CA9-EC2C9C993180 Q26859118-5887CD98-2340-48BD-AE66-BF5E0005AF19 Q30361645-3C8BB436-A0A2-40FB-8873-096109F3BAF6 Q30435948-6CC61388-6609-4014-BFA6-A350701F057C Q30747665-A718CB8C-AB8A-42C3-B234-0818F5EEF6C8 Q33883038-3D58713B-57C9-401C-AD1A-B0F8D8AD8A82 Q33963339-72DE3B61-466D-4267-8C30-CEAD4566BBA8 Q34091040-55060B7F-DD88-4638-B32F-70599E8F11A3 Q34484320-6CEB5F49-C776-40DE-AD95-5CEEE5157280 Q34779049-65E575F0-75C9-4280-87FA-AFC215373994 Q35100100-9EA2C2A8-AAEF-4C84-9127-41E4C396F414 Q35532673-61D45704-E67D-452C-B006-1020F8FE8004 Q35683422-834CD023-AEEB-4604-94A8-A5D93BD8471D Q35788887-E689CB90-9425-4231-9C40-124D3137ECC8 Q36405031-E207C13A-A70E-42DA-9A3C-A3AF85D93CCE Q36470460-8543FE77-6670-4DA2-9523-B76600C9BFB2 Q36777932-73A3D0A8-42C2-46BE-A258-620CF2ED287C Q36848280-CD3EB21F-2559-4995-91F3-46D399EC7DA4 Q37046576-4B7A97F0-5C4F-413A-8B40-2997FDD8A93A Q37073866-91403245-DFFD-4A7D-B19F-2012D2049A29 Q37596984-FD516782-3293-438E-ABB2-2FC6888C50F7 Q37606349-DA7B83C0-A6E0-4ADD-9E90-48403316F0C5 Q37636566-95DC67AE-D4FA-4454-B25F-6BDE10AEA87E Q37798824-3B2752DF-083F-49FC-AB46-F04E70BCC0B5 Q37811071-3880ED7B-E42C-478A-866A-260FC8FBB169 Q37957955-E5854632-7FA7-4479-B9A1-E0BE6C48F3F0 Q38071935-BEA434F2-176B-41BE-AB6F-D9A591F2A1E0 Q38128548-B05D8981-1E78-4463-86B0-3F7346FF7175 Q38204970-FD573D0A-DFC4-4B5B-8177-24E5FFA31DDA Q38592767-8336457E-B3E7-4BAA-A41A-F670B14ADDDB Q38644618-1A9205CA-57DB-47BC-AC73-15C78C79E204 Q39208263-21EE16EB-4524-486E-976A-7C7DE5567DDA Q39658315-52133E2F-217A-405E-B2A5-AB18DD7B7972 Q39800763-639E640A-495E-421B-8928-BA956FC2D494 Q40470046-2BCDEACF-3C87-41C6-AFC3-95943D92953B Q40501773-C2D6D50D-E86E-47CF-BA99-7C28F86A3648 Q40705552-5B1ABC87-2832-444E-9005-847CF1A085A4 Q41191108-958F8B5C-F372-48BB-94F5-2718CC87D508 Q41345966-7D8E062A-49AB-4549-A0F6-A2B9C296EF20

P2860

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q51492450

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Metabolic and adipokine profil ...... alcoholic fatty liver disease.

@en

Metabolic and adipokine profil ...... alcoholic fatty liver disease.

@nl

type

label

Metabolic and adipokine profil ...... alcoholic fatty liver disease.

@en

Metabolic and adipokine profil ...... alcoholic fatty liver disease.

@nl

prefLabel

Metabolic and adipokine profil ...... alcoholic fatty liver disease.

@en

Metabolic and adipokine profil ...... alcoholic fatty liver disease.

@nl

P1433

Q51492450-20656236-A71B-4915-9640-EDB5B54A6D99

P1476

Q51492450-B152EA36-051B-4D5D-8AB4-06085991C946

P2093

Q51492450-09F13C5D-72DC-40B2-B52F-3016C7D211D4

Q51492450-0B80F985-9E35-4CCD-B069-2423F671797B

Q51492450-49645773-8937-4C25-A6A7-A03895237787

Q51492450-4B5C5A1D-8D3F-4478-B6F7-87E3E94004E4

Q51492450-4F01084A-AE11-4F50-ABC2-04728E831CE3

Q51492450-7CFE2842-7BA9-4E92-B6BE-1FB73E9AC5E6

Q51492450-7F1772A5-BAD2-48ED-BD28-4582D0C9F64D

Q51492450-82691B50-4180-4FAC-B803-CA0C8EB810B1

Q51492450-AF954F2B-2C37-4C5D-B2B3-7024F8B5D988

Q51492450-CC50E1FF-503B-41FA-8932-A715464B3330

P304

Q51492450-C77CF92E-85C1-473F-B556-5888067ED1B5

P31

Q51492450-E8FEB709-2527-4E65-9A9D-FAF6A9E9322A

P356

Q51492450-9F90598F-1B88-45C5-AFF5-5122CE0C0BA2

P407

Q51492450-E98A7D14-995A-4F5B-8C1A-91CA2A14E6C5

P433

Q51492450-757DE104-77BF-4899-B586-ED8DCCC9EF98

P478

Q51492450-46C04DD8-48E0-477E-978C-72C3BDF440A4

P50

Q51492450-F0990854-3066-47E4-8245-37A249F30A4B

P577

Q51492450-5984B351-46B8-4AC8-BD5A-754D740186C2

P698

Q51492450-4E193D87-2F3F-4518-BC94-6DACBE1C3AEE

P921

Q51492450-18898ABE-EC7E-419A-BB3B-6C7DE7A921BC

P356

J.CGH.2006.06.011

P1433

Clinical Gastroenterology and Hepatology

P1476

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease

@en

P2093

Ada Mei-Ling Tse

http://www.w3.org/2001/XMLSchema#string

Alex Yui Hui

http://www.w3.org/2001/XMLSchema#string

Angela Yuen-Shan Cheng

http://www.w3.org/2001/XMLSchema#string

Grace Lai-Hung Wong

http://www.w3.org/2001/XMLSchema#string

Henry Lik-Yuen Chan

http://www.w3.org/2001/XMLSchema#string

Joyce Lai-Yee Chan

http://www.w3.org/2001/XMLSchema#string

Kui-Fat Chan

http://www.w3.org/2001/XMLSchema#string

Steven Woon-Choy Tsang

http://www.w3.org/2001/XMLSchema#string

Vincent Wai-Sun Wong

http://www.w3.org/2001/XMLSchema#string

Wing-Fung Ng

http://www.w3.org/2001/XMLSchema#string

P304

1154-1161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2006.06.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Joseph J Y Sung

P577

2006-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16904946

http://www.w3.org/2001/XMLSchema#string

P921